Columbia Research Enhanced Value ETF (NYSEARCA:REVS) Short Interest Down 56.7% in April

Columbia Research Enhanced Value ETF (NYSEARCA:REVS) saw a large decline in short interest in April. As of April 30th, there was short interest totaling 24,551 shares, a decline of 56.7% from the April 15th total of 56,757 shares. Based on an average daily volume of 29,012 shares, the short-interest ratio is presently 0.8 days. Approximately 0.3% of the shares of the stock are short sold.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Steward Partners Investment Advisory LLC purchased a new stake in shares of Columbia Research Enhanced Value ETF during the 4th quarter worth approximately $37,000. Cetera Investment Advisers purchased a new stake in shares of Columbia Research Enhanced Value ETF during the 1st quarter worth approximately $300,000. Essex Financial Services Inc. raised its holdings in shares of Columbia Research Enhanced Value ETF by 46.1% during the 3rd quarter. Essex Financial Services Inc. now owns 11,811 shares of the company’s stock worth $330,000 after acquiring an additional 3,725 shares in the last quarter. Private Advisor Group LLC purchased a new stake in shares of Columbia Research Enhanced Value ETF during the 3rd quarter worth approximately $448,000. Finally, Commonwealth Equity Services LLC raised its holdings in shares of Columbia Research Enhanced Value ETF by 14.8% during the 4th quarter. Commonwealth Equity Services LLC now owns 24,788 shares of the company’s stock worth $701,000 after acquiring an additional 3,191 shares in the last quarter.

Columbia Research Enhanced Value ETF Stock Down 0.9%

NYSEARCA REVS traded down $0.29 during trading hours on Friday, reaching $30.76. The company’s stock had a trading volume of 22,857 shares, compared to its average volume of 62,276. The firm’s 50-day moving average price is $29.49 and its 200-day moving average price is $29.07. Columbia Research Enhanced Value ETF has a 1 year low of $24.92 and a 1 year high of $31.18. The company has a market capitalization of $282.99 million, a price-to-earnings ratio of 16.41 and a beta of 0.80.

About Columbia Research Enhanced Value ETF

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.